Lung cancer patients who reported symptoms to their doctors via a smartphone application showed remarkably higher survival rates than patients using standard office visit schedules. The Wall Street Journal reported that, according to researchers, 75% of patients using the app were alive after 12 months, compared to 49% of patients receiving standard treatment. One hypothesis is that the more frequent monitoring and reporting of symptoms through the app led to patients being in better health at the time of a cancer relapse and that this better health led to increased survival rates. If these results are replicable, look for a proliferation of symptom reporting apps to hit the market and changes to cancer treatment protocols going forward. Way to go, science!